Skip to content

Flatiron Health UK at HETT Show 2024

Visit us at Stand G74

We’re thrilled to be part of the HETT Show 2024 on September 24th and 25th at ExCeL London! Join us at our case study session in the Integrated Care Forum to hear about our approach to working with NHS Trusts to improve the quality and availability of data to advance cancer research and care.

Transforming Cancer Research and Care with Real-World Data

Flatiron Health UK is on a mission to improve and extend lives by learning from the experience of every person with cancer.

Through clinical data and data science, and adherence to strict data privacy requirements, we translate actual patient experiences into real-world evidence to improve patient outcomes, inform policy and advance research.

We’re fully approved by the NHS Health Research Authority, including the Confidentiality Advisory Group and Research Ethics Committee.

Flatiron Health UK is uniquely placed to work with the NHS to build a comprehensive picture of cancer care in the UK. We already partner with the National Institute for Health and Care Excellence (NICE), Health Data Research-UK (HDR-UK) and DATA-CAN (HDR-UK’s Hub for Cancer), and we involve patients in everything we do.

Flatiron real-world data has contributed to publications across a range of solid and haematological malignancies. In the US, our data is having a tangible impact in cancer care, for example, men with breast cancer now have a therapy option previously only available to women, and patients with EGFR-mutations for some cancers now have a more convenient dosing regimen

Flatiron is proud to join the UK's vibrant science, data, and research community, collaborating with the NHS on our shared goals of driving improvements in cancer care and outcomes.

SCROLL TO:

Featured speaking sessions

Transforming Cancer Research and Care with Real-World Data: Flatiron Health UK’s Impactful Collaboration with the NHS

Wednesday, September 25

10:55 AM – 11:15 AM BST

Join Flatiron Health UK as we discuss our strategy for collaborating with NHS Trusts to enhance cancer research and care through improved data quality and accessibility. We’ll delve into our partnership with Leeds Teaching Hospitals NHS Trust, highlighting the positive impact it has on patients, the public, and the NHS.

presenter

Emma Salib

Manager, Strategic Partnerships, Flatiron Health UK

Meet our experts

Adam-Manhi

Adam Manhi

Head of Network & Commercial Partnerships, Flatiron Health UK

Emma-Salib-1

Emma Salib

Manager, Strategic Partnerships, Flatiron Health UK

Arun

Arun Sujenthiran, FRCS, MD(Res)

Clinical & Scientific Lead, International


Additional resources

Working in partnership to unlock the power of NHS data and transform cancer research and care

Leeds Teaching Hospitals NHS Trust and Flatiron UK are partnering to enhance cancer research by improving and standardising NHS data, benefiting patient care.

Three ways the NHS can benefit from partnering with Flatiron Health UK

Flatiron Health enhances NHS capabilities by transforming fragmented cancer patient data into valuable evidence, improving research, care delivery, and revenue.

Why data and technology are essential to reimagining the infrastructure of cancer care

Discover how data and technology are reshaping cancer care—streamlining clinical trials, enhancing personalised treatments, and bringing us closer to a future where every patient’s journey is improved.

Looking to transform care and outcomes for cancer patients through high-quality real-world data?

We’re proud to partner with NHS partners like Leeds Teaching Hospitals and are eager to expand our oncology evidence network in the UK.

As an NHS partner, you'll benefit from:

Access to a highly curated, comprehensive and regularly updated dataset capturing the full journey of cancer patients in your network for research, clinical and operational uses.

Access to our global oncology datasets, including data from the UK, US, Japan, and Germany, via our Trusted Research Environment, ensuring full compliance with local regulatory requirements.

A share in the financial value generated from approved researchers accessing our anonymised datasets.

Investment and support from us to facilitate the partnership on your end (i.e. technical and project management resources).

You’ll find us at HETT Show 2024, Stand G74 — drop by and say hello!

Request a meeting